home / stock / bimuf / bimuf quote
Last: | $0.0936 |
---|---|
Change Percent: | -28.0% |
Open: | $0.13 |
Close: | $0.0936 |
High: | $0.13 |
Low: | $0.0936 |
Volume: | 10,250 |
Last Trade Date Time: | 05/27/2021 04:41:20 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0936 | $0.13 | $0.0936 | $0.13 | $0.0936 | 10,250 | 05-27-2021 |
$0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 2,000 | 05-24-2021 |
$0.0991 | $0.09909 | $0.0991 | $0.0991 | $0.0991 | 366 | 05-21-2021 |
$0.0981 | $0.09797 | $0.0981 | $0.0981 | $0.098 | 30,000 | 05-13-2021 |
$0.1072 | $0.10275 | $0.1072 | $0.1072 | $0.1 | 37,425 | 05-11-2021 |
$0.0781 | $0.0781 | $0.0781 | $0.0781 | $0.0781 | 1,000 | 05-07-2021 |
$0.0774 | $0.0787 | $0.0774 | $0.0787 | $0.0774 | 3,850 | 05-04-2021 |
$0.085 | $0.08082 | $0.085 | $0.085 | $0.0808 | 40,000 | 04-29-2021 |
$0.0666 | $0.0666 | $0.0666 | $0.0666 | $0.0666 | 500 | 04-16-2021 |
$0.0749 | $0.0758 | $0.0749 | $0.0758 | $0.0743 | 37,389 | 04-15-2021 |
$0.0782 | $0.078224 | $0.0782 | $0.0782 | $0.0727 | 4,000 | 04-09-2021 |
$0.0784 | $0.0784 | $0.0784 | $0.0784 | $0.0784 | 1,000 | 03-31-2021 |
$0.0745 | $0.07445 | $0.0745 | $0.0745 | $0.0745 | 100 | 03-29-2021 |
$0.0819 | $0.08194 | $0.0819 | $0.0819 | $0.0819 | 100 | 03-25-2021 |
$0.0839 | $0.0839 | $0.0839 | $0.0839 | $0.0839 | 2,000 | 03-22-2021 |
$0.084 | $0.084 | $0.084 | $0.084 | $0.084 | 1,000 | 03-15-2021 |
$0.0868 | $0.08684 | $0.0868 | $0.0868 | $0.0868 | 300 | 03-10-2021 |
$0.071 | $0.07099 | $0.071 | $0.071 | $0.071 | 1,040 | 03-09-2021 |
$0.08 | $0.078 | $0.08 | $0.08 | $0.078 | 300 | 03-05-2021 |
$0.0736 | $0.08 | $0.0736 | $0.08 | $0.0717 | 2,200 | 03-04-2021 |
News, Short Squeeze, Breakout and More Instantly...
Biommune Technologies Inc Company Name:
BIMUF Stock Symbol:
OTCMKTS Market:
VANCOUVER, BC / ACCESSWIRE / March 22, 2021 / Pascal Biosciences Inc. (" Pascal " or the " Company ") (TSXV:PAS)(OTC PINK:BIMUF), a biotechnology company that specializes in cancer, cannabinoids, and Covid-19 is announcing several management changes following its recent capital raise. First,...
NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / March 17, 2021 / Pascal Biosciences Inc. (" Pascal " or the " Company ") (TSXV:PAS)(OTC PINK:BIMUF), a biotechnology company that specializes in cancer, cannabinoids...
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / January 21, 2021 / Pascal Biosciences, Inc. (" Pascal " or the " Company ") (TSXV:PAS)(OTC PINK:BIMUF), will present at the first Cannabinoid Derived Pharmaceuticals Industry Review Summit today. Dr. Patrick Gray, CEO of Pascal Biosciences,...